Literature DB >> 3578244

Visceral larva migrans in French adults: a new disease syndrome?

L T Glickman, J F Magnaval, L M Domanski, F S Shofer, S S Lauria, B Gottstein, B Brochier.   

Abstract

Visceral larva migrans is apparently an endemic disease among adults in southwest France. Thirty-seven adults living in the Midi-Pyrenees region of France were confirmed as having visceral larva migrans based on an increased specific antibody titer to Toxocara canis as detected by enzyme-linked immunosorbent assay (ELISA) and by the Western blot method. The disease was characterized clinically by weakness, pruritus, rash, difficulty breathing, abdominal pain, and pathologically by allergic manifestations including eosinophilia and increased serum immunoglobulin (Ig) E levels. Conditional logistic regression analysis using a control group of 37 hospital patients with other conditions who were individually matched to patients with visceral larva migrans by age and sex revealed an increased risk for visceral larva migrans associated with hunting or living in a household with a hunter (odds ratio (OR) = 9.0, p = 0.02) and with living in a village of less than 500 persons (OR = 5.7, p = 0.04). Owning two or more dogs compared with owning one or no dogs increased the risk of visceral larva migrans for hunting or living in a household with a hunter (OR = 9.6 vs. OR = 4.5) and for persons living in nonhunting households (OR = 2.1 vs. OR = 1.0). These findings, however, could not be duplicated when 60 age- and sex-matched neighbors were used as a second control group.

Entities:  

Mesh:

Year:  1987        PMID: 3578244     DOI: 10.1093/oxfordjournals.aje.a114618

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Environmental and serological evidence for the presence of toxocariasis in the urban area of Ancona, Italy.

Authors:  A Giacometti; O Cirioni; M Fortuna; P Osimani; L Antonicelli; M S Del Prete; A Riva; M M D'Errico; E Petrelli; G Scalise
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Apparent weak efficacy of ivermectin for treatment of human toxocariasis.

Authors:  J F Magnaval
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

Review 3.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 4.  Highlights of human toxocariasis.

Authors:  J F Magnaval; L T Glickman; P Dorchies; B Morassin
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

5.  Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis.

Authors:  H Yamasaki; K Araki; P K Lim; N Zasmy; J W Mak; R Taib; T Aoki
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Hepatic visceral larva migrans.

Authors:  Seema Rohilla; Nitin Jain; Rohtas Yadav; Dhara Ballabh Dhaulakhandi
Journal:  BMJ Case Rep       Date:  2013-07-13

7.  Ultrastructural localization of Toxocara canis larval antigen reacted with a seropositive human serum.

Authors:  Soo-Ung Lee; Jae-Ran Yu; Sun Huh
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

8.  Application of the western blotting procedure for the immunodiagnosis of human toxocariasis.

Authors:  J F Magnaval; R Fabre; P Maurières; J P Charlet; B de Larrard
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

9.  Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis.

Authors:  J F Magnaval; R Fabre; P Maurières; J P Charlet; B de Larrard
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

10.  Immunodiagnosis of toxocarosis in humans: evaluation of a new enzyme-linked immunosorbent assay kit.

Authors:  P Jacquier; B Gottstein; Y Stingelin; J Eckert
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.